Patients with cancer are often at increased risk for infections due to their weakened immune systems, which can be a result of the cancer itself or from treatments like chemotherapy and radiation therapy. These treatments can reduce the number of healthy white blood cells, making it harder for the body to fight infections. Amikacin is particularly useful in treating bacterial infections in these immunocompromised patients.
